At the end of 2022, the federal government eliminated the "X waiver," a major hurdle to providing addiction treatment, but progress needs to be continued, according to the authors of a new Perspective piece published in the ...
May 1, 2023
0
32
New research from Boston Medical Center found that increasing the use of underutilized asset building programs could be part of the solution to help build wealth for low income families. Published in Pediatrics, the study ...
Apr 6, 2023
0
5
Despite the heightened poverty and unemployment seen when the COVID-19 pandemic got underway, many low-income U.S. children did not experience a decline in their emotional and mental health, we found in a new study.
Mar 27, 2023
0
3
President Joe Biden's 2024 proposed budget includes plans to shore up the finances of Medicare, the federal health insurance program that covers Americans who are 65 and up and some younger people with disabilities.
Mar 17, 2023
1
3
If you get health care coverage through Medicaid, you might be at risk of losing that coverage over the next year.
Feb 26, 2023
0
14
A world-first study has found an education approach used widely by sport organizations to stop harmful homophobic behavior and other forms of discrimination is ineffective.
Feb 13, 2023
0
3
Eligible older adults who participate in the Supplemental Nutrition Assistance Program (SNAP) in the United States may have slower memory decline than eligible people who do not participate, according to a new study at Columbia ...
Nov 9, 2022
0
10
Thousands of cattle are covered in blisters from highly infectious foot-and-mouth disease in Indonesia, sounding the alarm for the country, its Southeast Asian neighbors and Australia. The virus found in two provinces in ...
Jul 21, 2022
0
3
Annual cancer deaths in sub-Saharan Africa (SSA) could reach 1 million by 2030, nearly double the 520,000 deaths from cancer that occurred in 2020. Cancer incidence is also projected to double by 2040 to more than 1.4 million ...
May 9, 2022
0
3
U.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alzheimer's therapy that the company hailed as a breakthrough for patients.
Nov 22, 2021
0
2
